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The long-term objective of the NIGMS PSI
is to obtain a complete description of pro-
tein fold space using the approach of
structural genomics. As the term struc-
tural genomics implies, the PSI was con-
ceived as a next step in the postgenomics
era. However, the PSI is fundamentally
different from the genome sequencing
effort after which it is fashioned. Deter-
mining the sequence of a specific genome
is a finite, well-defined problem. While it is
clear that each gene has a sequence,
each gene product does not have ‘‘a
structure’’ because proteins usually have
multiple functional states resulting from
factors such as posttranslational modifi-
cations, conformational changes induced
by the binding of ligands, induction of
structure in functional regions that appear
disordered when the protein is studied on
its own, and function in more than one
multiprotein complex. Thus, it is not cer-
tain that the fundamental goal of the PSI
is achievable or even well defined. Is ‘‘fac-
tory-scale’’ science an appropriate model
for structural biology as it is for DNA
sequencing?
Even if 3D structures could be obtained
from most open reading frames, one still
needs to ask how valuable these struc-
tures are. The PSI produces structures
of proteins whose functions and future
utility are not known. Structure, by itself,
rarely provides the mechanistic insight
that comes from a combined approach
of structure, biochemistry, cell biology,
and genetics. If functional information is
not available, the structure will usually
have very limited practical significance.
Largely in response to such criticisms
and the general skepticism of the greater
structural biology community, structural
genomics programs have begun to
change. A number of new spin-off objec-
tives have emerged, in particular putting
emphasis on various aspects of technol-
ogy development for high-throughput12 Structure 16, January 2008 ª2008 Elseviestructure determination. These changes
are good developments, as they reflect
the need to alter the central focus and bet-
ter align it with an approach that will truly
reflect the high impact and vast potential
associated implicitly with such a broad
term as Protein Structure Initiative.
At a practical level, the long-term PSI
objective is a relevant academic pursuit
to advance understanding of protein fold
space and the protein folding problem. It
has been argued that good coverage of
fold space will facilitate homology model-
ing. Formally, this is true. However, unless
the sequence identity is very high, homol-
ogymodeling is not able to provide chem-
ically reliable models. Consequently, ho-
mology models are not useful for many
applications, such as drug discovery,
where rational inhibitor design requires
knowledge of the precise chemistry of
molecular interactions. While improving
modeling methods to the point that we
could reliably know chemistry is a laud-
able goal, adding more folds to the struc-
tural database is not what is required to
achieve this objective. Rather, fundamen-
tal advances in physical chemistry and
associated computational methods need
to be made.
PSI Outcomes
The comparison of the PSI and ongoing
structural biology is inevitable. The field
of structural biology is now focused on
central structural challenges relevant to
medicine and biology (e.g., membrane
proteins, protein complexes, and the
mechanism of action of multiprotein cellu-
lar machinery). In contrast, the PSI is not
organized in a way such that a single
structure will have high value. At present,
the most important outcomes from the
PSI relate to methodology for structure
determination.
There is no question that structural biol-
ogy has benefited from the development
of technologies to facilitate structurer Ltd All rights reserveddetermination. Can these advancements
be attributed solely to the PSI? The struc-
tural biology community has consistently
pushed over many years to find ways to
make structure determination easier.
Moreover, there have been many critical
contributions from the commercial sector.
While it is unclear howmuch credit the PSI
can take, there is no question that the
advent of the PSI has helped to focus
many of these efforts.
The most important contributions of the
PSI have been for X-ray crystallography:
the development and routine use of robot-
ics and remote data collection at synchro-
trons, as well as the development of soft-
ware. The greatest impact has come from
the ability to screen many crystals, which
has greatly improved the efficiency of
data collection and structure determina-
tion, especially for challenging problems.
Another useful development has been
centers that perform large-scale robotic
screens for crystallization conditions,
and provide access to this technology
for laboratories that cannot afford their
own systems.
The overall benefit of the PSI for exper-
imental techniques other than crystallog-
raphy seems minimal. Progress in the
NMR field toward increased efficiency in
data acquisition and automating structure
determination software for small proteins
is partly attributable to the PSI. However,
these developments have not had a large
impact on the really pressing problems
associated with frontier areas such as
membrane proteins, other large proteins,
and protein complexes. Any effect on
other experimental methods has only
been indirect.
Protein expression technology devel-
opment was anticipated to be advanced
by the PSI, but so far, no new approaches
have proven to be especially useful. The
problem seems to be that parallelization
of standard production protocols is useful
only for very specific problems. Also, the
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possible in the shortest amount of time
may have de-emphasized development
of methods to deal with difficult, high-
risk problems. Another factor is that the
scale of much of what has been devel-
oped at PSI centers is out of reach for
an individual or a small group of investiga-
tors, particularly at smaller institutions.
Another important factor in the discus-
sion is metrics for evaluation. For exam-
ple, it has been stated that the cost of
structure determination has been lowered
by the PSI. However, the PSI model of
selecting proteins accessible to rapid
structure determination guarantees low
cost. The calculations ignore the more
expensive and less straightforward bio-
chemical and functional studies that are
carried out in problem-focused laborato-
ries whose objective is to determine the
structure of a specific protein. Thus, for
most important targets today, the major
investment is almost always in the optimi-
zation of system. Therefore, the PSI cost/
structure represents an achievable mini-
mum under ideal circumstances but not
the actual cost for performing structural
biology.
One concern is whether the really diffi-
cult challenges in structural biology are
being left aside in the emphasis on high
throughput? The PSI develops a highly fo-
cused set of technologies, but these are
not necessarily those most important for
the significant structural challenges of
the future. For example, an emphasis on
approaches that use multiple structural
methods will be critically important going
forward, but this does not fit in a natural
way into the current PSI portfolio. As
long as success is measured by the num-
ber of new structures produced, there will
be a disincentive to take on challenging
problems. The innovative work needed
for these challenges continues to come
from individual labs with experience in
working with particular protein systems.
And to what end do PSI goals serve
education? How well can students or
post-docs be trained in structural geno-
mics when there are only very global
hypotheses—no models to be tested, no
important biological problems to be illu-
minated? At best, structural genomics
trains our future researchers in mastering
an important set of skills, but not in how
to think. Hence, many investigators for
whom training is a central element donot participate in PSI activities because
the training for structural genomics is
purely technical in nature.
Finally, there is the inevitable discus-
sion of funding. While the PSI was initially
based on ‘‘separate’’ funds during the
rapid growth period for NIH funding, that
time is well past. The argument of how
funds can be most efficiently expended
falls strongly on the side of investigator
initiated R01 proposals. The R01 enables
a nimble scientific community to apply
a diversity of approaches and reshape
priorities rapidly, a system that regener-
ates itself well by selecting the most com-
petent and creative individuals. To those
who serve on review panels it is clear
that the current funding squeeze is most
felt by investigators involved in methods
development who are not supported
through the PSI.
A New Vision for the PSI
We are in an era where structural analysis
is being incorporated widely in biomedical
research, so a protein structure initiative
in some form is fully warranted. It is impor-
tant to accept that the return on such
a substantial investment needs to be sig-
nificant or there will be negative effects in
the long term. Given that the PSI already
exists, we need to find a way forward.
The emphasis should not be on what is
wrong with the current implementation
of the PSI. Rather, it should focus on
how the objectives and corresponding
programs can be altered to achieve the
level needed to significantly impact cur-
rent biomedical research. The primary
message being sent from the structural
biology community is that this will require
an adjustment to the intellectual para-
digm, and to be most effective, a consen-
sus among a substantial portion of the
structural biology community needs to
be generated.
A modified PSI should reflect the fact
that the true power of structural analysis
is the ability to explain biological systems
and medicine in terms of chemical and
physical principles. In this context, the
most important mechanistic insights
come from seeing proteins bound to rele-
vant targets. And beyond static structure,
it is increasingly clear that the dynamic
nature of biomacromolecules must be
addressed. Both the internal conforma-
tional dynamics of proteins and the dy-
namics of protein machinery are essentialStructure 16, January 20to understanding how proteins function.
These critical aspects must be incorpo-
rated into any Protein Structure Initiative.
In essence, the challenge is to create
a PSI that operates in a functionally savvy
way.
Further comment is warranted on the
issue of dynamics. The PSI concept is
based strictly on a static structural view,
i.e., there is a single set of coordinates
for each gene sequence. In the last de-
cade, a significant number of studies
from FRET, single molecule fluorescence,
computational molecular dynamics,
NMR, and ultrahigh-resolution X-ray dif-
fraction have revealed that biomolecules
are better described as dynamic ensem-
bles than as static structures. Since the
ultimate goal of structural biology is to un-
derstand how proteins function, the PSI
program needs to include an understand-
ing of functional dynamics. Dynamics is
also essential to understanding the work-
ings of complex multiprotein machinery,
which must constantly be remodeled;
both intrinsic molecular motions and dy-
namical remodeling of protein assemblies
must be characterized. The character-
ization of dynamic processes requires
knowledge of timescale, amplitude, an-
isotropy, and correlation of movements.
Experimental methods to determine these
parameters and to represent them com-
prehensibly are still in their infancy and
much basic research in experimental
methodology is required. The potential
payoff from this knowledge is vast, not
only for understanding protein function,
but also, for example, for developing
new paradigms for research in the devel-
opment of new pharmaceuticals. Thus,
beyond determining static structures,
the PSI must incorporate efforts to de-
velop the corresponding technology to
analyze the dynamic aspects so central
to protein function.
The modified PSI should place the em-
phasis squarely on development of tech-
nologies to enhance the ability to meet
the grand challenges in structural biology.
One aspect already well advanced is the
enhancement of facilities unavailable to
individual laboratories, such as synchro-
trons. It is equally important to include
a focused effort to develop the foundation
technologies to undertake structure
determination in individual laboratories.
The value and impact of structure deter-
mination is highestwhen it is performed as08 ª2008 Elsevier Ltd All rights reserved 13
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team research. Moreover, to address fun-
damental problems in medicine and biol-
ogy, there is no one tool that can provide
all the answers. Thus, in addition to devel-
oping specific technologies, a second set
of programs is envisioned, focusing on
bringing together topic- or disease-based
expertise with multiple structural method-
ologies to work on a key problem in med-
icine and biology. For these teams, an
emphasis would also be placed on devel-
oping approaches to foster integration of
the structural expertise and technologists
with functional analyses of the system
under investigation. The objective here is
to demonstrate the power of integration
by achieving successes in specific areas
of high biomedical relevance. This aspect
of the PSI would lead naturally to partner-Comparative Mod
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The genome sequencing revolution has
resulted in a dramatic increase in the de-
mand for structural information, a demand
that traditional structural biology is totally
unable to meet. The chance that a se-
quenced protein domain will have an
experimental structure is already near
0.1% and that ratio is falling fast. All over
the world, molecular and cell biologists
are staring in frustration at the sequences
of their proteins of interest, wishing they
had structure. In recognition of this,
a number of structural genomics projects,
the NIH Protein Structure Initiative (PSI) in
particular, have set out to maximize the
number of protein domains for which
structural information is available. Inher-
ent in the strategy is leverage of experi-
mental information through comparative
modeling of related structures.
There is no doubt that for some pur-
poses an experimental structure, or in-
deed awhole series of structures, is highly
14 Structure 16, January 2008 ª2008 Elseviships with disease-based institutes at
NIH.
How would this modified PSI operate?
The key feature is that rather than devel-
oping a small number of very large cen-
ters, the new PSI strategy would involve
a series of tightly coordinated smaller
groups, each with a specific focus that
feeds into the overall technology devel-
opment plan. These delocalized and
smaller-scale teams would be built
around institutional and regional groups
of investigators who can interact readily
on a daily basis. The smaller size and
larger number of research teams will pro-
vide for a much greater degree of flexibil-
ity and adaptability. In this scenario, there
has to be a very strong central organiza-
tional structure responsible for maintain-
ing a high degree of coordination of theeling in Structural
ogy, University of Maryland Biotechnology Insti
desirable in order to obtain the necessary
understanding of the system of interest.
For example, if the goal is structure-based
drug design, an experimental high-resolu-
tion crystal structure of the protein and
relevant complexes is almost essential
(although even for this most demanding
application, there are a number of reports
of drug design on models, for example,
Becker et al., 2006). But such applications
are not in fact typical, and the output of
the PSI and other structural genomics
projects is aimed at a much broader set
of possible uses. To assess the utility of
its strategy, we must ask how useful the
models are to the full range of relevant
biologists.
The lowest resolution models, typically
produced by remote fold relationship rec-
ognition and not refined, have many er-
rors, but are nevertheless usually just
fine for such applications as recognizing
approximate domain boundaries (often
er Ltd All rights reservedresearch efforts and facile exchange
between the various teams. This group
could be housed at one of the existing
PSI sites or on the NIH campus.
The NIGMS PSI is evolving and the time
is ripe to make key modifications in re-
sponse to new knowledge and the chang-
ing environment. Generating a consensus
across the structural biology community
and focusing on grand structural chal-
lenges will enhance the PSI and result in
high impact on the biomedical research
enterprise.
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critical for successful expression; Tress
et al., 2007), assigning approximate func-
tion (by identifying members of a known
superfamily), or selection of epitopes
for vaccine development (Nassal et al.,
2007). Medium resolution models, typi-
cally at the limit of detection of a structural
relationship using PSI-BLAST, and unre-
fined, may be used for a range of addi-
tional purposes, such as detecting likely
sites of protein-protein interactions (Kras-
ley et al., 2006), identifying the approxi-
mate role of disease-associated substitu-
tions (Ye et al., 2006), or assessing the
likely role of alternative splicing in protein
function (Wang et al., 2005). Higher reso-
lution models, derived from relationships
with better than about 30% sequence
identity or refined from lower resolution
starting models, add such uses as mole-
cule replacement in solving a crystal
structure (Qian et al., 2007), providing
a detailed interpretation of the impact of
